Published in Am J Physiol on September 01, 1982
Studies with iontophoretic administration of drugs to human dermal vessels in vivo: cholinergic vasodilatation is mediated by dilator prostanoids rather than nitric oxide. Br J Clin Pharmacol (1998) 1.02
Classical Renin-Angiotensin system in kidney physiology. Compr Physiol (2014) 0.92
Involvement of endothelium-derived relaxing factor in the pressure control of renin secretion from isolated perfused kidney. J Clin Invest (1993) 0.91
A major role for the EP4 receptor in regulation of renin. Am J Physiol Renal Physiol (2011) 0.88
Effect of melittin on renin and prostaglandin E2 release from rat renal cortical slices. J Physiol (1990) 0.75
Flow-induced release of endothelium-derived relaxing factor. Am J Physiol (1986) 3.51
Bacterial interference. I. Its occurrence among the respiratory tract flora and characterization of inhibition of group A streptococci by viridans streptococci. J Infect Dis (1969) 3.09
Determinants of participation in state-of-the-art cancer prevention, early detection/screening, and treatment trials among African-Americans. Cancer Nurs (1993) 2.87
Sisomicin: evaluation in vitro and comparison with gentamicin and tobramycin. Antimicrob Agents Chemother (1973) 2.47
Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin. N Engl J Med (1968) 2.44
Noninvasive measurement of concurrent single-kidney perfusion, glomerular filtration, and tubular function. Am J Physiol Renal Physiol (2001) 1.99
Noninvasive evaluation of a novel swine model of renal artery stenosis. J Am Soc Nephrol (1999) 1.96
Treatment of hyperthyroidism with sodium iodide I-131. JAMA (1966) 1.93
Efficacy of rifampin in treatment of meningococcal carriers. N Engl J Med (1969) 1.89
Scintigraphic localization of pheochromocytoma. N Engl J Med (1981) 1.88
Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med (1985) 1.72
Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine. J Nucl Med (1980) 1.62
Subacute idiopathic demyelinating polyradiculoneuropathy. Arch Neurol (1992) 1.60
Detection of functional iron deficiency during erythropoietin treatment: a new approach. BMJ (1992) 1.50
The HIV epidemic and the state of its surveillance in Ethiopia. Ethiop Med J (2000) 1.45
Is there complete cross-resistance of gram-negative bacilli to gentamicin and tobramycin? Antimicrob Agents Chemother (1972) 1.44
Increased oxidative stress in experimental renovascular hypertension. Hypertension (2001) 1.44
Three-dimensional microcomputed tomography of renal vasculature in rats. Hypertension (1998) 1.43
Neuromuscular blockade associated with gentamicin therapy. JAMA (1971) 1.42
Health status of Mya arenaria bivalves collected from contaminated sites in Canada (Saguenay Fjord) and Denmark (Odense Fjord) during their reproductive period. Ecotoxicol Environ Saf (2005) 1.41
The Mycobacterium tuberculosis 38-kDa antigen: overproduction in Escherichia coli, purification and characterization. Gene (1992) 1.41
The degradation of human glomerular basement membrane with purified lysosomal proteinases: evidence for the pathogenic role of the polymorphonuclear leucocyte in glomerulonephritis. Clin Sci Mol Med (1978) 1.38
Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med (1981) 1.31
Epidemiology of sulfonamide-resistant meningococcal infections in a civilian population. Am J Epidemiol (1971) 1.27
Endothelium-derived relaxing factor inhibits renin release. Eur J Pharmacol (1988) 1.27
Effects of NG-nitro-L-arginine methyl ester on renal function and blood pressure. Am J Physiol (1991) 1.26
Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer. J Nucl Med (1976) 1.26
High-fructose feeding elicits insulin resistance, hyperinsulinism, and hypertension in normal mongrel dogs. Hypertension (1994) 1.22
Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma. J Nucl Med (1987) 1.22
Role of the endothelium-dependent relaxing factor nitric oxide on renal function. J Am Soc Nephrol (1992) 1.22
Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med (1981) 1.21
Salivary gland accumulation of meta-[131I]iodobenzylguanidine. J Nucl Med (1984) 1.21
Prognostic implications of the tall cell variant of papillary thyroid carcinoma. Am J Surg Pathol (1988) 1.20
Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med (1987) 1.18
Renal and nephron hemodynamics in spontaneously hypertensive rats. Am J Physiol (1979) 1.17
Antioxidants block angiotensin II-induced increases in blood pressure and endothelin. Hypertension (2001) 1.17
Treatment of thyroid cancer. Death rates after surgery and after surgery followed by sodium iodide I-131. JAMA (1970) 1.16
Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumors. Semin Nucl Med (1985) 1.14
Computed tomography-derived intrarenal blood flow in renovascular and essential hypertension. Kidney Int (1996) 1.13
Right aortic arch symptomatic in adulthood. Neth J Med (2002) 1.12
New horizons for therapeutic nuclear medicine in 1981. J Nucl Med (1981) 1.11
Radiopharmaceutical treatment of malignant pheochromocytoma. J Nucl Med (1984) 1.11
Thermal regulation in patients after the healing of large deep burns. Plast Reconstr Surg (1973) 1.10
Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis. Circulation (2001) 1.09
Lincomycin versus erythromycin: a choice or an echo. Ann Intern Med (1969) 1.08
The effect of tailoring a model HIV prevention program for local adolescent target audiences. AIDS Educ Prev (2000) 1.08
Cyclooxygenase-2 mediates increased renal renin content induced by low-sodium diet. Hypertension (1997) 1.07
The effect of indomethacin and other anti-inflammatory drugs on the renin-angiotensin system. J Clin Invest (1976) 1.07
A new and superior adrenal imaging agent, 131I-6beta-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans. J Clin Endocrinol Metab (1977) 1.06
Spectrum of pheochromocytoma in multiple endocrine neoplasia. A scintigraphic portrayal using 131I-metaiodobenzylguanidine. Ann Intern Med (1981) 1.06
Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients. Transplantation (1993) 1.03
Bone-alkaline phosphatase as indicator of bone formation. Clin Chim Acta (1991) 1.03
Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide. Hypertension (1992) 1.02
Acute intrinsic renal failure induced by indomethacin: role of prostaglandin synthetase inhibition. Mayo Clin Proc (1982) 1.01
Effect of prostanoids on renin release from rabbit afferent arterioles with and without macula densa. Kidney Int (1989) 1.01
Seroprevalence of hepatitis markers; HAV, HBV, HCV and HEV amongst primary school children in Freetown, Sierra Leone. West Afr J Med (1998) 1.01
Effects of NG-monomethyl-L-arginine and L-arginine on acetylcholine renal response. Hypertension (1990) 1.01
Pheochromocytoma and the normal adrenal medulla: improved visualization with I-123 MIBG scintigraphy. Radiology (1985) 1.01
The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy. J Nucl Med (1983) 1.00
Prevention of meningococcal infections. J Infect Dis (1970) 1.00
Visualizing human malignant melanoma and metastases. Use of chloroquine analog tagged with iodine 125. JAMA (1968) 1.00
Endothelium-derived relaxing factor regulates renin release in vivo. Am J Physiol (1992) 1.00
Radiation dosimetry of 131I-19-iodocholesterol. J Nucl Med (1973) 1.00
An analysis of "ablation of thyroid remnants" with I-131 in 511 patients from 1947-1984: experience at University of Michigan. J Nucl Med (1984) 0.99
Immunity to Mycobacterium tuberculosis in mice. Effect of heterologous mycobacteria in relation to quantitative and qualitative differences in their organ localization. Am Rev Respir Dis (1969) 0.99
Adrenal scintigraphy. Semin Nucl Med (1978) 0.99
Unusual complications of antithyroid drug therapy: four case reports and review of literature. Thyroidology (1989) 0.99
Quantitation of the in vivo kidney volume with cine computed tomography. Invest Radiol (1990) 0.99
Imaging the primate adrenal medulla with [123I] and [131I] meta-iodobenzylguanidine: concise communication. J Nucl Med (1981) 0.98
Cyclosporine-induced hypertension after transplantation. Mayo Clin Proc (1994) 0.97
The treatment of thyroid carcinoma with radioactive iodine. Semin Nucl Med (1978) 0.97
Two-dimensional noise-robust blind deconvolution of ultrasound images. IEEE Trans Ultrason Ferroelectr Freq Control (2001) 0.97
Measurement of renal perfusion and blood flow with fast computed tomography. Circ Res (1994) 0.96
Role of endothelin and isoprostanes in slow pressor responses to angiotensin II. Hypertension (2001) 0.96
The scintigraphic imaging of endocrine organs. Endocr Rev (1984) 0.95
Electrolyte and water balance in young spontaneously hypertensive rats. Hypertension (1983) 0.95
Angiotensin II: nitric oxide interaction and the distribution of blood flow. Am J Physiol (1993) 0.95
Microcomputed tomography of kidneys following chronic bile duct ligation. Kidney Int (2000) 0.95
Circulating biomarkers. Thromb Res (2012) 0.95
Response to angiotensin inhibition in rats with sustained renovascular hypertension correlates with response to removing renal artery stenosis. J Vasc Surg (1998) 0.94
Salt-induced increase in arterial pressure during nitric oxide synthesis inhibition. Hypertension (1993) 0.94
Influence of nitric oxide in the chronic phase of two-kidney, one clip renovascular hypertension. Hypertension (1998) 0.94
Hormonal, renal, and metabolic alterations during hypertension induced by chronic inhibition of NO in rats. Am J Physiol (1994) 0.94
Angiotensin dependence of endothelium-mediated renal hemodynamics. Hypertension (1992) 0.94
Performance of routine syphilis serology in the Ethiopian cohort on HIV/AIDS. Sex Transm Infect (2004) 0.94
Evolution of chronic nitric oxide inhibition hypertension: relationship to renal function. Hypertension (1998) 0.93
Combination of hypercholesterolemia and hypertension augments renal function abnormalities. Hypertension (2001) 0.93
Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes. Diabet Med (2004) 0.92
Renal tubular reabsorption in spontaneously hypertensive rats. Am J Physiol (1979) 0.92
Renal nitric oxide and angiotensin II interaction in renovascular hypertension. Hypertension (1993) 0.92
Correlation of brain scan image and area counting after scanning with tumor pathology. J Nucl Med (1966) 0.92
Calibration of a proton beam energy monitor. Med Phys (2007) 0.91
Subpressor doses of angiotensin II increase plasma F(2)-isoprostanes in rats. Hypertension (2000) 0.91
Diagnosis of adrenal disease by visualization of human adrenal glands with 131 I-19-iodocholesterol. N Engl J Med (1971) 0.91
Low CD4+ T-cell count and high HIV viral load precede the development of tuberculosis disease in a cohort of HIV-positive ethiopians. Int J Tuberc Lung Dis (2003) 0.91
Renal effects of angiotensin II inhibition during increases in renal venous pressure. Hypertension (1992) 0.90
Metabolic fate of drugs: barbiturates and closely related compounds. Annu Rev Pharmacol (1967) 0.90
Prostaglandin generation from gastroduodenal mucosa: regional and species differences. Prostaglandins (1982) 0.90
Inverse relationship between cardiac accumulation of meta-[131I]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma. J Nucl Med (1983) 0.89